Cargando…
核苷酸还原酶M1在晚期非小细胞肺癌治疗和预后中的作用
Lung cancer is one of the most common and highest mortality rates malignant tumors, further, 75%-80% is non-small cell lung cancer (NSCLC). For the majority of patients, lost the chance of radical operation or radiotherapy, chemotherapy is the main treatment. However, because of the diversities of t...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999903/ https://www.ncbi.nlm.nih.gov/pubmed/26104896 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.09 |